Cargando…
Safety of laboratory analyzers for infection testing - results of the market surveillance by the BfArM until end 2007
The European Directive 98/79/EC on in vitro diagnostic medical devices (IVD) stipulates the marketing and post market surveillance of IVD in the European Economic Area. In cases of issues and field corrective actions, the manufacturers have to inform the responsible Competent Authorities (CA). In Ge...
Autores principales: | Siekmeier, R, Halbauer, J, Mientus, W, Wetzel, D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3521334/ https://www.ncbi.nlm.nih.gov/pubmed/20156760 http://dx.doi.org/10.1186/2047-783X-14-S4-216 |
Ejemplares similares
-
Field safety notices released by manufacturers in cases of failure of products for infection testing: analysis of cases reported to the BfArM between 2005 and 2007
por: Siekmeier, R, et al.
Publicado: (2010) -
Beitrag des BfArM zur Potenzialentfaltung der Digitalisierung im Gesundheitswesen – digital readiness@BfArM
por: Broich, Karl, et al.
Publicado: (2021) -
Innovationsunterstützung im BfArM – Erfahrungen aus den Beratungen zu digitalen Gesundheitsanwendungen (DiGA)
por: Löbker, Wiebke, et al.
Publicado: (2021) -
A 1-year cross-sectional analysis of non-interventional post-marketing study protocols submitted to the German Federal Institute for Drugs and Medical Devices (BfArM)
por: von Jeinsen, Beatrice K. J. G., et al.
Publicado: (2013) -
Digitale Gesundheitsanwendungen (DiGA): Bewertung der Erstattungsfähigkeit mittels DiGA-Fast-Track-Verfahrens im Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM)
por: Lauer, Wolfgang, et al.
Publicado: (2021)